EISAI INC. for EISAI INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Ongoing discussions and updates on Helsinn v. Teva
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Health Issues HCR
Regulatory and legislative health care issues impacting pricing and access * Regulatory and legislative health care issues, including the 340B program * Issues related to diagnosis and treatment of Alzheimer's Disease * FDA Guidance on Alzheimer's Drug Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Medicare/Medicaid MMM
Potential Pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. * H.R. 1530/S. 595 -- Treat and Reduce Obesity Act of 2019 * Revisions to Medicare reimbursement programs Changes to reimbursement structure of Medicare Part D Program Changes to coverage policy for certain drugs in Medicare Part D program Proposed Part B International Pricing Index Demonstration program Changes to rebate structure of Medicare Part D program
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.